blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3805243

EP3805243 - ANDROSTANE DERIVATIVES WITH ACTIVITY AS PURE OR PREDOMINANTLY PURE STIMULATORS OF SERCA2A FOR THE TREATMENT OF HEART FAILURE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.09.2024
Database last updated on 07.10.2024
FormerThe patent has been granted
Status updated on  13.10.2023
FormerGrant of patent is intended
Status updated on  19.07.2023
FormerRequest for examination was made
Status updated on  28.06.2023
FormerGrant of patent is intended
Status updated on  04.06.2023
FormerRequest for examination was made
Status updated on  08.05.2023
FormerGrant of patent is intended
Status updated on  30.03.2023
FormerRequest for examination was made
Status updated on  02.07.2021
FormerThe application has been published
Status updated on  12.03.2021
Most recent event   Tooltip19.09.2024No opposition filed within time limitpublished on 23.10.2024 [2024/43]
Applicant(s)For all designated states
Windtree Therapeutics, Inc.
2600 Kelly Road, Suite 100
Warrington, PA 18976-3622 / US
[2021/29]
Former [2021/15]For all designated states
Windtree Therapeutics, Inc.
2600 Kelly Road, Suite 100
Warrington, PA 18976-3622 / US
For all designated states
Università degli Studi di Milano - Bicocca
Piazza dell'Ateneo Nuovo, 1
20126 Milano / IT
Inventor(s)01 / CERRI, Alberto
""
deceased / IT
02 / FERRARI, Patrizia
Via Gasparotto 57
21100 Varese / IT
03 / FERRANDI, Mara
Via Cenisio 34
20100 Milano / IT
04 / BARASSI, Paolo
Via Campagnetta 6B
21010 Castelvaccana (VA) / IT
05 / BIANCHI, Giuseppe
Piazza Adigrat 4
20133 Milano / IT
06 / HSU, Shin-Che
3F.,No,50,Aly.119,Ln.103,Sec.2
Neihu Rd Neihu Dist
TAIWAN / CN
07 / PERI, Francesco
Via Chopin 99
20141 Milano / IT
08 / ZAZA, Antonio
Via Vincenzo Foppa 11
20144 Milano / IT
09 / ROCCHETTI, Marcella
Vialle della Vittoria 30/A
20861 Brugherio (MB) / IT
10 / LURAGHI, Andrea
Via M.D'Azeglio 1
20023 Cerro Maggiore / IT
11 / TORRE, Eleonora
Via Segantini 25
20832 Desio (MB) / IT
12 / RONCHI, Carlotta
Via Budua 6
20159 Milano / IT
 [2023/46]
Former [2021/15]01 / CERRI, Alberto
""
deceased / IT
02 / FERRARI, Patrizia
Via Gasparotto 57
21100 Varese / IT
03 / FERRANDI, Mara
Via Cenisio 34
20100 Milano / IT
04 / BARASSI, Paolo
Via Campagnetta 6B
21010 Castelvaccana (VA) / IT
05 / BIANCHI, Giuseppe
Piazza Adigrat 4
20133 Milano / IR
06 / HSU, Shin-Che
3F.,No,50,Aly.119,Ln.103,Sec.2
Neihu Rd Neihu Dist
TAIWAN / CN
07 / PERI, Francesco
Via Chopin 99
20141 Milano / IT
08 / ZAZA, Antonio
Via Vincenzo Foppa 11
20144 Milano / IT
09 / ROCCHETTI, Marcella
Vialle della Vittoria 30/A
20861 Brugherio (MB) / IT
10 / LURAGHI, Andrea
Via M.D'Azeglio 1
20023 Cerro Maggiore / IT
11 / TORRE, Eleonora
Via Segantini 25
20832 Desio (MB) / IT
12 / RONCHI, Carlotta
Via Budua 6
20159 Milano / IT
Representative(s)Cantaluppi, Stefano, et al
Cantaluppi & Partners S.r.l.
Via A. Canova, 2
20145 Milano / IT
[2023/46]
Former [2021/15]Ghirardi, Valeria, et al
Cantaluppi & Partners S.r.l.
Via Strobel, 8
20133 Milano / IT
Application number, filing date19202257.209.10.2019
[2021/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3805243
Date:14.04.2021
Language:EN
[2021/15]
Type: B1 Patent specification 
No.:EP3805243
Date:15.11.2023
Language:EN
[2023/46]
Search report(s)(Supplementary) European search report - dispatched on:EP12.03.2020
ClassificationIPC:C07J1/00, C07J41/00, C07J43/00, A61K31/566, A61K31/58, A61P9/04, // C07J21/00, C07J51/00
[2021/15]
CPC:
C07J1/0011 (EP,CN,IL,KR,US); A61K31/56 (KR); A61K45/06 (US);
A61P9/04 (CN,KR); C07J1/0022 (EP,IL); C07J21/008 (EP,IL);
C07J41/0038 (EP,IL,KR); C07J41/0088 (EP,CN,IL,KR); C07J43/003 (EP,CN,IL,KR);
C07J51/00 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/31]
Former [2021/15]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ANDROSTANDERIVATE MIT WIRKUNG ALS REINE ODER VORWIEGEND REINE STIMULATOREN VON SERCA2A ZUR BEHANDLUNG VON HERZVERSAGEN[2021/15]
English:ANDROSTANE DERIVATIVES WITH ACTIVITY AS PURE OR PREDOMINANTLY PURE STIMULATORS OF SERCA2A FOR THE TREATMENT OF HEART FAILURE[2021/15]
French:DÉRIVÉS D'ANDROSTANE AYANT UNE ACTIVITÉ DE STIMULATEURS PURS OU MAJORITAIREMENT PURS DE SERCA2A POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE[2021/15]
Examination procedure30.06.2021Examination requested  [2021/31]
30.06.2021Date on which the examining division has become responsible
23.05.2022Amendment by applicant (claims and/or description)
31.03.2023Communication of intention to grant the patent
08.05.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
05.06.2023Communication of intention to grant the patent
27.06.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
20.07.2023Communication of intention to grant the patent
29.09.2023Fee for grant paid
29.09.2023Fee for publishing/printing paid
29.09.2023Receipt of the translation of the claim(s)
Opposition(s)19.08.2024No opposition filed within time limit [2024/43]
Fees paidRenewal fee
29.09.2021Renewal fee patent year 03
15.09.2022Renewal fee patent year 04
13.09.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipEE15.11.2023
HR15.11.2023
LT15.11.2023
LV15.11.2023
RO15.11.2023
RS15.11.2023
SK15.11.2023
SM15.11.2023
BG15.02.2024
IS15.03.2024
PT15.03.2024
[2024/36]
Former [2024/35]EE15.11.2023
HR15.11.2023
LT15.11.2023
LV15.11.2023
RO15.11.2023
RS15.11.2023
SM15.11.2023
BG15.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/34]EE15.11.2023
HR15.11.2023
LT15.11.2023
LV15.11.2023
RS15.11.2023
SM15.11.2023
BG15.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/33]HR15.11.2023
LT15.11.2023
LV15.11.2023
RS15.11.2023
SM15.11.2023
BG15.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/26]HR15.11.2023
LT15.11.2023
LV15.11.2023
RS15.11.2023
BG15.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/25]HR15.11.2023
LT15.11.2023
RS15.11.2023
BG15.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/21]LT15.11.2023
BG15.02.2024
IS15.03.2024
Documents cited:Search[A]US3580905  (BROWN IVOR JAMES STEWART, et al);
 [AD]EP0825197  (SIGMA TAU IND FARMACEUTI [IT]);
 [XI]WO2007118830  (SIGMA TAU IND FARMACEUTI [IT], et al);
 [A]WO2007118832  (SIGMA TAU IND FARMACEUTI [IT], et al);
by applicantUS4534899
 US5605674
 US5716928
 EP0825197
 US5846743
 US5858401
 US5874268
 US6007839
 US6063400
 US6261815
 US6358530
 US6509006
 US6589503
 US6592904
 US2004028670
 US2004151766
 US2005136121
 US2006083737
 US7097827
 US7109034
 US2007042031
 US2007077286
 US2007082042
 US2007110798
 US7306783
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.